Rock Springs Capital Management LP raised its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 0.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,035,000 shares of the company’s stock after purchasing an additional 2,400 shares during […]
Rock Springs Capital Management LP grew its position in shares of Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 16.0% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 363,468 shares of the company’s stock after purchasing an additional 50,000 shares during […]
Inozyme Pharma (NASDAQ:INZY – Get Free Report)‘s stock had its “outperform” rating restated by equities researchers at Wedbush in a report released on Tuesday, RTT News reports. They presently have a $15.00 price target on the stock. Wedbush’s price target indicates a potential upside of 368.75% from the company’s previous close. A number of other […]